Get started
GENSCRIPT BIOTECH CORPORATIONGENSCRIPT BIOTECH CORPORATIONGENSCRIPT BIOTECH CORPORATION

GENSCRIPT BIOTECH CORPORATION

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

1548 chart

Key stats

Market capitalization
‪26.96 B‬HKD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.36HKD
Net income
‪−747.48 M‬HKD
Revenue
‪6.57 B‬HKD
Shares float
‪1.08 B‬
Beta (1Y)
1.42

About GENSCRIPT BIOTECH CORPORATION

Sector
Health Technology
Industry
Biotechnology
CEO
Weihui Shao
Website
genscript.com
Headquarters
Nanjing
Employees (FY)
‪6.94 K‬
Founded
2002
ISIN
KYG3825B1059
FIGI
BBG009XY51J1
Genscript Biotech Corp. is a holding company, which engages in the manufacture and sale of life sciences research products and services. It operates through the following segments: Bio-science Services and Products; Precision Immune-cell Therapy; and Industrial Synthetic Biology Products. The Bio-science Services and Products segment includes life sciences research services, life sciences research catalogue products, and preclinical drug development services. The Precision Immune-cell Therapy segment discovers and develops therapies for the treatment of liquid tumour through optimised CAR structures and the development of bispecific CAR-T therapies. The Industrial Synthetic Biology Products segment comprises of the construction of non-pathogenic microbial strains and industrial enzyme development and production. The company was founded by Fang Liang Zhang, Lu Quan Wang, and Ye Wang in 2002 and is headquartered in Nanjing, China.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 1548 is 11.64 HKD — it has decreased by 4.28% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange GENSCRIPT BIOTECH CORPORATION stocks are traded under the ticker 1548.
GENSCRIPT BIOTECH CORPORATION is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for GENSCRIPT BIOTECH CORPORATION has a max estimate of 31.04 HKD and a min estimate of 23.02 HKD.
Yes, you can track GENSCRIPT BIOTECH CORPORATION financials in yearly and quarterly reports right on TradingView.
Like other stocks, 1548 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENSCRIPT BIOTECH CORPORATION stock right from TradingView charts — choose your broker and connect to your account.
1548 reached its all-time high on Jul 20, 2021 with the price of 43.40 HKD, and its all-time low was 1.08 HKD and was reached on May 27, 2016.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has ‪6.94 K‬ employees. See our rating of the largest employees — is GENSCRIPT BIOTECH CORPORATION on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENSCRIPT BIOTECH CORPORATION EBITDA is ‪−2.47 B‬ HKD, and current EBITDA margin is −37.65%. See more stats in GENSCRIPT BIOTECH CORPORATION financial statements.